UBS Predicts Massive Growth for Marvell's CXL Tech

UBS has significantly increased its price target for Marvell Technology, signaling strong investor confidence in the company's future data center growth. The analyst firm raised its target to $340, while maintaining a Buy rating, underscoring Marvell's critical role in the evolving Compute Express Link (CXL) market.

CXL technology is designed to enhance the synergy between chips and memory within data centers. This is increasingly crucial as artificial intelligence systems demand greater efficiency and scalability. UBS anticipates the CXL market will grow to $4.5 billion by 2027 and potentially reach $7 billion to $10 billion by 2030.

Marvell is strategically positioned to capitalize on this expansion, with UBS forecasting approximately $1 billion in CXL revenue for the company in 2027. This growth is largely attributed to its involvement in XPU-attached designs, including collaborations with major U.S. hyperscalers. The firm also updated its revenue estimates for Marvell, projecting $16.8 billion for 2027 and $23.9 billion for 2028.

While the prospect of a new major growth avenue beyond its current data center business is appealing for investors, the key risk lies in Marvell's ability to convert these anticipated design wins into tangible revenue within the projected timelines.